Vynca
United States
- Palo Alto, CA
- 31/01/2022
- Series C
- $30,000,000
Vynca enables high-quality, person-centered, goal-concordant care that reflects individuals’ wishes with their serious illness management platform that incorporates virtual palliative care services, advance care planning, care coordination, symptom management, whole-person care and provider engagement. The company’s comprehensive solution set empowers providers, individuals and their families to have meaningful conversations about future care preferences supported by a broad range of serious illness management services offered from a single point of trust to deliver successful value-based arrangements to healthcare organizations. With this approach, Vynca is able to ensure that personalized end-of-life care is available for every individual, every time.
- Industry Hospital & Health Care
- Website https://vyncahealth.com/
- LinkedIn https://www.linkedin.com/company/vynca/
Ciphero | $2,500,000 | (Dec 23, 2025)
beycome | $2,500,000 | (Dec 23, 2025)
Givefront | $2,000,000 | (Dec 23, 2025)
StretchSense | $2,300,000 | (Dec 23, 2025)
ZeroPhase | $6,800,000 | (Dec 23, 2025)
Peripheral Labs | $3,600,000 | (Dec 23, 2025)
Ethereal Exploration Guild | $21,000,000 | (Dec 23, 2025)
LatentForce | $1,700,000 | (Dec 23, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)